Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (24)

2024

  1. Long or complicated mpox in patients with uncontrolled HIV infection

    Journal of Medical Virology, Vol. 96, Núm. 3

  2. Molecular and phylogenetic characterization of the monkeypox outbreak in the South of Spain

    Health Science Reports, Vol. 7, Núm. 3

  3. Social and clinical predictors of perianal colonisation by multidrug-resistant bacteria for geriatric patients in the internal medicine service

    Infection, Vol. 52, Núm. 1, pp. 231-241

  4. The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers

    Journal of Clinical Investigation, Vol. 134, Núm. 8

  5. Time-restricted eating and supervised exercise for improving hepatic steatosis and cardiometabolic health in adults with obesity: protocol for the TEMPUS randomised controlled trial

    BMJ Open, Vol. 14, Núm. 1

  6. Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain

    Pediatric Infectious Disease Journal, Vol. 43, Núm. 1, pp. 40-48

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers

    Clinical Microbiology and Infection, Vol. 29, Núm. 1, pp. 85-93

  3. Detection of High Level of Co-Infection and the Emergence of Novel SARS CoV-2 Delta-Omicron and Omicron-Omicron Recombinants in the Epidemiological Surveillance of Andalusia

    International journal of molecular sciences, Vol. 24, Núm. 3

  4. Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

    Viruses, Vol. 15, Núm. 7

  5. Gut Microbiota Composition Can Predict Colonization by Multidrug-Resistant Bacteria in SARS-CoV-2 Patients in Intensive Care Unit: A Pilot Study

    Antibiotics, Vol. 12, Núm. 3

  6. Identification of compounds with activity against Trypanosoma cruzi within a collection of synthetic nucleoside analogs

    Frontiers in Cellular and Infection Microbiology, Vol. 12

  7. Molecular characterization of patients with chronic hepatitis C virus infection in Jordan: implications on response to direct-acting antiviral therapy

    International Journal of Infectious Diseases, Vol. 135, pp. 63-66

  8. Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response

    Biomedicine and Pharmacotherapy, Vol. 163

  9. Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis

    Open Forum Infectious Diseases, Vol. 10, Núm. 11

2022

  1. Dalbavancin in clinical practice in Spain: A 2 year retrospective study

    JAC-Antimicrobial Resistance, Vol. 4, Núm. 6

  2. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  3. Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019

    HIV Medicine, Vol. 23, Núm. 7, pp. 705-716

  4. High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use

    Journal of Infection, Vol. 85, Núm. 3, pp. 322-326

  5. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19

    Frontiers in Immunology, Vol. 13